SUMMARY The large differences in the spin lattice relaxation times (T1) of blood and myocardium (measured by nuclear magnetic resonance) allow the heart to be visualised without the use of contrast media. The findings using nuclear magnetic resonance in 11 unselected patients with hypertrophic cardiomyopathy were compared with those in equal numbers of normal subjects and patients with electrocardiographic features of left ventricular hypertrophy. In patients with hypertrophic cardiomyopathy characteristic septal hypertrophy was noted together with variable and sometimes pronounced hypertrophy of the left ventricular free wall, which is consistent with the heterogeneous nature of this disease. The mean (SD) ratio of septal to free wall thickness was 1*5(0-8) for patients with hypertrophic cardiomyopathy, 0.8(0.2) for those with left ventricular hypertrophy, and 0*9(0*2) for normal subjects. Although septal measurements by nuclear magnetic resonance were greater than those obtained by echocardiography there was a significant correlation between the two. Septal and free wall area were significantly smaller in normal subjects. There were no differences in septal or free wall T, values between the three groups.
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Non-gated nuclear magnetic resonance can detect septal and free wall hypertrophy. With the addition of multiple slice acquisition, rapid estimation of myocardial mass will be possible allowing the potentially important assessment of progression or regression of myocardial hypertrophy. SPIN LATTICE RELAXATION TIME (T,) Table 2 shows the mean values for T1. There was no significant difference between patient groups, although septal T1 was consistently higher than free wall T1 for all groups (p<001).
Discussion
This study shows the ability of nuclear magnetic resonance to outline the interventricular septum and left ventricular free wall and to. detect differences in myocardial thickness in patients with increased afterload and hypertrophic cardiomyopathy when contrasted with normal subjects. The pronounced contrast between flowing blood, which gives a high signal intensity, and the chamber walls allows hypertrophy to be demonstrated since there is also contrast between myocardium and surrounding tissues.
Within the group of patients with hypertrophic cardiomyopathy large variations in septal area were found. In those cases in which a diagnosis of hypertrophic cardiomyopathy could confidently be made by nuclear magnetic resonance the findings on echocardiography were more impressive ( Stone et al recently reported the appearances of hypertrophic cardiomyopathy obtained with nongated computed tomography using contrast medium in nine patients.7 Visualisation of the septum was good and showed the variability of the position of maximal septal hypertrophy. Definition of the left ventricular free wall was, however, poor and inadequate for measurements. By using the differences in the relaxation index T1 between flowing blood and ventricular muscle, nuclear magnetic resonance can allow clear visualisation of both septum and free wall without the use of contrast agents.
It was not the purpose of this study to compare nuclear magnetic resonance with echocardiography as there is a large difference in their cost and stage of development. There is also a wide variation in purchase and installation costs between different nuclear magnetic resonance systems and the variables they measure. The system we used is a low cost low magnetic field system. Echocardiography has contributed to the understanding of hypertrophic cardiomyopathy (for example, in determining the cause and level of obstruction when present8) and is of value in making the diagnosis. Echocardiographic features are not, however, specific individually.5 M mode echocardiography gives diagnostic information in over 85% of patients, but precise measurements of left ventricular dimensions are possible in only 60-65% of patients.9 Real time echocardiography improves diagnostic ability, and because of its rapidity and widespread availability echocardiography will remain the commonest and most practical technique for confirming hypertrophic cardiomyopathy. Nevertheless, nuclear magnetic resonance is possible in most patients and may be helpful in those in whom echocardiographic quality is poor.
The differences observed between our three groups were from images taken without cardiac gating. The extent by which gating improves resolution in nuclear magnetic resonance is not yet established. Some reports have emphasised the need for cardiac gating to obtain satisfactory anatomical information. 10 Choyke et al, however, have shown that images of diagnostic quality were obtained without gating using single spin echo sequences with a very short echo time (10-20 ms).1 l In practice it gives a very similar echo time to that used in our own system. They had noted pronounced degradation of the image with longer echo times and concluded that the previous unfavourable reports using non-gated techniques may have been due to longer echo times used in other centres.
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The ability to obtain measurements of myocardial area and thus by multiple slice acquisition to estimate myocardial mass may prove valuable in the follow up of patients with myocardial hypertrophy. Drug treatment in both patients with hypertension and those with hypertrophic cardiomyopathy should ideally result in a reduction in muscle mass. The noninvasive nature of nuclear magnetic resonance makes this an attractive method for long term assessment of such patients.
